Marín-Jiménez, J. A., Oliva, M., Peinado Martín, P., Cabezas-Camarero, S., Plana Serrahima, M., Vázquez Masedo, M. G., . . . Mesía, R. (2022). Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy.
Citación estilo ChicagoMarín-Jiménez, Juan A., et al. Paclitaxel Plus Cetuximab As Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy. 2022.
Cita MLAMarín-Jiménez, Juan A., et al. Paclitaxel Plus Cetuximab As Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy. 2022.